LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Debate: Should the dose or duration of anticoagulants for the prevention of venous thrombosis be increased in patients with COVID‐19 while we are awaiting the results of clinical trials?

Photo by nci from unsplash

Keith Gomez, Mike Laffan and Charlotte Bradbury Haemophilia Centre and Thrombosis Unit, Royal Free Hospital London NHS Foundation Trust, London, Department of Immunity and Inflammation, Centre for Haematology, Faculty of… Click to show full abstract

Keith Gomez, Mike Laffan and Charlotte Bradbury Haemophilia Centre and Thrombosis Unit, Royal Free Hospital London NHS Foundation Trust, London, Department of Immunity and Inflammation, Centre for Haematology, Faculty of Medicine, Imperial College London, London, Faculty of Translational Health Sciences, University of Bristol, Bristol, and University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK

Keywords: dose duration; duration anticoagulants; prevention venous; anticoagulants prevention; thrombosis; debate dose

Journal Title: British Journal of Haematology
Year Published: 2020

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.